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Abstract 
Background: The initiation of environmental public health tracking systems in the USA and the 
UK provided an opportunity to advance techniques and tools available for spatial epidemiological 
analysis integrating both health and environmental data. 
 
Objective: The Rapid Inquiry Facility (RIFallows users to calculate adjusted and unadjusted 
standardized rates and risks.  The RIF is embedded in ArcGIS so that further GIS spatial 
functionality can be exploited or results can be exported to statistical packages for further tailored 
analyses where required. The RIF also links directly to several statistical packages and displays 
the results in the GIS. 
 
Methods: The value of the RIF is illustrated here with two case studies: risk of leukaemia in areas 
surrounding oil refineries in Utah State (USA) and an analysis of the geographical variation of 
risk of oesophageal cancer in relation to zinc cadmium sulphide exposure in Norwich (UK). 
 
Results: The risk analysis study in Utah did not suggest any evidence of increased risk of 
leukemia, multiple myeloma or Hodgkin’s lymphoma in the populations around the five oil 
refining facilities, but did reveal an excess risk of NHL which might warrant further investigation. 
The disease mapping study in Norwich did not reveal any areas with higher risks of oesophageal 
cancer common to both males and females, suggesting that a common geographically determined 
exposure was unlikely to be influencing cancer risk in the area. 
 
Conclusion: The RIF offers a tool that allows epidemiologists to quickly carry out ecological 
environmental epidemiological analysis such as risk assessment or disease mapping.
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Introduction 
Recent interests in developing ‘environmental public health tracking’ systems, particularly in the 
USA and the UK, have provided an opportunity to advance techniques for spatial epidemiological 
analysis.  The Centers for Disease Control and Prevention (CDC) and the Small Area Health 
Statistics Unit, UK (SAHSU) have collaborated to adapt and enhance a tool for evaluating spatial 
relationships between health and environmental risk factors, for use in CDC’s National 
Environmental Public Health Tracking (EPHT) programme (http://www.cdc.gov/nceh/tracking/). 
 
Since 2002, the CDC’s EPHT programme has worked with local and state environment and 
health agencies, federal agencies such as the Environmental Protection Agency (EPA), academic 
institutions and other non-governmental agencies to develop and enhance the ongoing collection, 
integration, analysis and interpretation of environmental hazards, human exposures to 
environmental hazards and non-infectious health effects potentially related to these exposures 
(McGeehin 2004).  The key functions of EPHT programme are 1) the compilation of a core set of 
nationally consistent health and environmental data and measures; 2) the discovery, description, 
exchange, analysis, and management of data; 3) to give access to tools for managing and 
analyzing the data; and 4) the provision of environmental public health information to the public 
(National Network Implementation Plan, 2006).  As part of this coordinated network to develop 
tools and methods a partnership between the EPHT network and the UK Small Area Health 
Statistics Unit (SAHSU) was initiated. 
 
The Small Area Health Statistics Unit (SAHSU) was established in 1987 following a 
recommendation of the Black enquiry (Black 1980) into the incidence of leukaemia in children 
and young adults near the Sellafield nuclear plant.  One of the main aims of SAHSU is to assess 
the risk to the health of the population from environmental factors, with an emphasis on the use 
and interpretation of routine health data.  A tool, the Rapid Inquiry Facility (RIF), was developed 
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at SAHSU to help staff respond rapidly, with expert advice, to ad hoc queries from funding 
departments about unusual clusters of disease, particularly in the neighbourhood of putative 
environmental hazard sources (Aylin et al. 1999). 
 
This early version of the RIF was designed specifically for use with SAHSU data. The RIF 
software and the processes behind it were then evaluated on a European level as part of the 
European health and environment information system for exposure and disease mapping and risk 
assessment project (EUROHEIS and EUROHEIS 2) with several EUROHEIS partners making 
changes to the RIF to facilitate its use in other European countries with their data (for example 
Ferrándiz et al 2003, Juhasz et al 2010). With the commencement of the CDC EPHT the RIF was 
seen as a valuable tool that, with further enhancement, could be used more widely, such as  in US 
state departments, to facilitate the process of responding to environmental health issues from 
policy makers and the public alike.   
 
This paper describes the development of this spatial epidemiological tool and reports on two case 
studies where the system has been used. 
 
The investigation of possible health effects around point sources of environmental pollution have 
traditionally been costly and time consuming since health and population data relevant to the area 
under study would need to be assembled and analysed ad hoc (Elliott et al. 1996).  Linking health, 
population and exposure data allows environmental public health practitioners to evaluate the 
spatial and temporal relations between environmental factors and health (McGeehin et al. 2004).  
Using geographical analysis spatial trends in rates and risks at different geographical scales can 
be assessed, potential clusters of disease can be identified and areas of rapid population change or 
areas of good or poor health event ascertainment highlighted.  
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The contribution that geographical information science can make to spatial epidemiology is 
increasingly being recognized (Elliott and Wartenberg 2004; Jarup 2004).  Ever growing numbers 
of epidemiological institutions and departments use geographical information systems (GIS) but 
health and population datasets used are not yet routinely stored in a GIS, instead, they are simply 
imported on an ad hoc basis.  The ability to undertake spatial analysis without the need for 
significant data manipulation is both valuable and offers tremendous time advantages. 
 
The RIF has been developed primarily to assess the links between environmental exposures, 
health outcomes and risk for group, or ecological level analysis using readily available aggregated 
health and population data such as those collected for censuses.  There are a number of inherent 
issues with ecological analysis which include problems with data availability and suitability, 
through to methodological challenges such as dealing with inconsistent geographical boundaries, 
different data scales, exposure misclassification and ecological bias (Elliott and Savitz 2008).  A 
number of different statistical methods can be used to estimate area-level risks and confidence 
intervals to give an assessment of associated uncertainty, which differ in suitability depending on 
the study (Beale et al. 2008).  The methods included within the RIF aim to minimise many of the 
limitations indicated above, whilst exploiting the advantages offered by high resolution data for 
large areas such as States or Countries, and over long periods of time.  
 
 
Methods 
The RIF has been described in detail elsewhere (Beale et al., 2008). Briefly, the RIF is embedded 
in a Geographical Information Systems (GIS) (requiring ESRI ArcGIS) and connects to an 
external database (e.g. Microsoft Access or Oracle) of geocoded health and population data.  This 
tight-coupled approach between a GIS and a database removes the need to explicitly gather data 
by study, saving on both time and data storage. 
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The RIF calculates directly standardised rates and indirectly standardised rate ratios in a user-
defined population.  Users can specify, via various means of selection or by spatial analyses, a 
‘study population’, such as the population living within a certain distance of a point or area source 
of pollution or the populations of administrative areas falling within the jurisdiction of a health 
authority.  All specified health events that occurred over the selected time period and that fall 
within this study area are retrieved, together with the relevant population data.  The RIF can 
handle any health coding (e.g. ICD, ICD-Oncology, SEER, and user defined codes) and for data 
coded using ICD-9 and ICD-10 (World Health Organisation 2004) lists are provided to enable 
health events to be selected by chapters, groups or individual codes.  Applying the study 
population sex- and age-specific disease rates to the reference region population generates 
directly standardised rates.  Indirectly standardised relative risks project the sex- and age-specific 
rates of the reference population to the age and sex structure of the study population producing 
standardized mortality (SMRs) or incidence ratios (SIRs).  When defining the study area users 
should take into account that the data requirements to support valid SIRs are less than the 
requirements to support directly age-adjusted rates.  In addition to sex and age, standardization by 
other covariate(s), such as socio-economic status (SES), ethnicity or income (where such data are 
available) is easily achieved. 
 
Two main types of analysis can be carried out using the RIF; risk analysis and disease mapping.  
Using risk analysis, associations between either proximity (to point, line or area sources), or 
exposure to a putative risk factor and health can be explored.  Rates and relative risks are 
calculated in user-defined distance bands around one or more sources, or levels of using exposure 
if such data are available.  Users can also run homogeneity and linear trend tests to check if the 
risk is statistically homogeneous across bands.   Disease mapping allows visualization of 
mortality or morbidity rates and spatial patterns of health at a user-defined geographical 
10 
 
resolution.  Maps are produced of rates and relative risks including smoothed (towards the global 
mean) relative risks, by empirical Bayesian estimation using the Poisson-Gamma model 
suggested by Kaldor and Clayton (1987).  The RIF can also link with external software such as 
SaTScan (Kulldorff 1995) to search for disease clusters as well as WinBUGS (Lunn et al. 2000) 
and INLA (Rue et al. 2009) to produce smoothed (towards the local mean) risks based on the 
fully Bayesian model proposed by Besag et al (1991). In all cases the results are mapped in the 
GIS. 
 
Data can be easily exported from the RIF so that numerator, denominator, rates and risks can be 
used elsewhere meaning the RIF adds functionality to the ‘epidemiologists’ tookit’ rather than 
replace existing tools or approaches.  For example, users can export data to MS EXCEL, 
WinBUGS (Lunn et al. 2000) and SaTScan (Kulldorff 1995).  In addition, the RIF can seamlessly 
generate reports in, for example, MS Word using XML structured data (text).   
 
The following sections illustrate the use of the RIF with two case studies: a risk analysis from the 
USA and a disease mapping analysis from the UK. 
 
 
Case Study: USA risk analysis 
Utah Department of Health began an investigation into a perceived excess of leukemia following 
requests from the local community at Woods Cross. 
 
Oil refining activities in Utah started as early as 1909 with approximately seven oil companies 
working in twenty-five wells near Mexican Hat, San Juan County (see Figure 1).  The first of five 
currently operating refineries located nearly adjacent to each other along an 11 kilometer north-
south corridor was built in 1932 (Harline 1963; Strack 2007). 
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These five refinery facilities process approximately 61 million barrels annually (Isaacson, 2005).  
Industries associated with oil refining are co-located with these refineries and several national 
priority list hazardous waste sites are found in the vicinity.   
 
In 2004, these five refineries reportedly released 161,000 kg of hazardous air emissions including 
benzene, cyclohexane, ethylbenzene and ethylene.  In addition, there are likely to be substantial 
fugitive releases of volatile organic hydrocarbon compounds (VOCs) from the transportation of 
oil by tanker truck and pipeline, transfer and processing of crude oil and from the storage of 
product, whilst refineries release a number of processing related air contaminants.  Leukemia, 
multiple myeloma, Hodgkin’s and non-Hodgkin lymphoma (NHL) have been associated with 
hazardous air emissions released by oil refineries (Infante 1993; Rushton 1993; San Sebastian et 
al. 2001, Smith et al. 2007). 
  
As it was not possible to accurately identify which populations were exposed, a pragmatic 
decision was made to assess risk in the census blocks within 2.5km and between 2.5 and 5km of 
the refineries.  These distances capture sufficiently sizeable populations for meaningful analysis, 
reflect differences in the topography of the area which may influence exposure, and conform to an 
earlier initial investigation enabling comparisons to be made..  The topography of Davis County 
forces the communities into a narrow band (approximately 10 km wide running north to south).  
The communities are bounded by the steep Wasatch Mountain Range on the east and the Great 
Salt Lake on the west.  Approximately 2.5 km east of the refinery the topography changes (due to 
Lake Bonneville an ancient parent inland sea), whilst at 2.5 km west of the refinery the land use 
transitions, from mixed suburban and agricultural use, to solely agricultural use.  Bountiful is 
approximately 5km south from the refineries at a higher elevation suggesting that it may be at risk 
from plumes from stack emissions; particularly given the predominant wind direction is 
12 
 
southerly.  Exposures at Woods Cross, within 2.5km, are more likely a result of fugitive 
emissions as it sits in the shadow of the plume.  Approximately 62,000 and 87,000 residents live 
within 2.5km and between 2.5 and 5.0 kilometers from the refineries respectively.   
Cancer incidence data on first primary leukemia (ICD9: 204-207; ICD10: C91-C95), multiple 
myeloma (ICD9: 203, ICD10: C90), Hodgkin’s (ICD9: 201; ICD10: C81) and non-Hodgkin’s 
lymphoma (NHL) (ICD9: 200, 202; ICD10: C82-85) among Utah residents from 1973 to 2006 
were obtained from the Utah Cancer Registry and investigated at census block group level.  The 
cancer data were geo-referenced by the Utah Environmental Public Health Tracking Network 
(UEPHTN) with over 98 percent being geo-referenced to census block groups using case report 
residential address.  Median income from the 2000 census was used to control for confounding by 
SES.  The latency for these cancers is generally assumed to be about 5 years, although longer 
latency periods have been reported (Crump and Allen 1984). 
 
Risk of Leukaemia, Multiple myeloma, Hodgkin’s and non-Hodgkin lymphoma (SIR) 
Cancer risk for populations of census blocks falling within 2.5 kilometers of the five facilities 
(encompassing the residential area of Woods Cross), and between 2.5 to 5.0 kilometers (capturing 
all surrounding communities) was compared to the cancer risk for the State of Utah.  Analysis 
was carried out, using the RIF, with 33 years of cancer incidence data to ensure stable estimates.    
Results are shown in Table 1.   
 
Only NHL was found to have risks that were statistically higher than would be expected given the 
reference rates of Utah.  The values show males living closest to the refineries had the highest 
risk.  The unadjusted and adjusted SIRs are virtually the same, suggesting that the excess risks of 
NHL within 2.5km of the oil refineries are not related to income. The socio-economic structure of 
the population in Bountiful has changed over the study period, so analyses were also carried out 
using income from 1990, but again income again had little to no effect on the overall results. 
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Exposures are hard to establish, and while refinery boundaries have remained pretty stable over 
the last 30 years the location of stacks and fugitive emissions sources have changed as plants have 
changed processes and/or built additional facilities and ancillary industries around these sites  
have changed in use, been abandoned or relocated over time (with some becoming super-fund 
sites).  The distance bands used in this study, although thoughtfully chosen, remain arbitrary 
boundaries.   
 
These analyses did not find any evidence of increased risk of leukemia, multiple myeloma or 
Hodgkin’s lymphoma in the populations around these five facilities.  An excess risk of NHL was 
found in populations living around the oil refineries, and exposure to emissions from these sites is 
a possible explanation (e.g. some research has linked to both leukemia and certain types of NHL 
to benzene exposure (Steinmaus et al. 2008)).  A male excess could also point to occupational 
exposure although a substantial number of the refinery employees lived outside of the study area 
(e.g. north Davis County and Salt Lake County).  Further investigation to identify what specific 
disease subtype is occurring, and whether environmental or occupational exposures have 
contributed to risk would need to be conducted.  
 
The above example shows how the RIF can help effectively use limited public health resources 
by identifying target populations who could most benefit from public health intervention, 
education and early screening clinics.  
 
Case Study: UK disease mapping 
Over the period 1953 to 1964, during the ‘cold war’, the British Ministry of Defence undertook 
an extensive programme of field trials to simulate the dissemination of toxic biological agents 
across the country (Academy of Medical Sciences to the Chief Scientific Adviser 2000).  The 
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field trials involved the release of zinc cadmium sulphide (ZnCdS) from static devices, vehicles, 
aircraft and ships.  An independent review of these UK trials concluded that exposure to cadmium 
from the dissemination of ZnCdS during the cold war should not have resulted in adverse health 
effects in the population (Elliott et al. 2002).  However in 2005, a local surgeon suggested that 
there was an increased risk of oesophageal cancer in Norwich caused by exposure of the local 
population to ZnCdS released by the Ministry of Defence in 1963.  
 
The UK Health Protection Agency (HPA) carried out a preliminary investigation to assess 
whether there was any evidence that the residents of the city of Norwich were at an increased risk 
of oesophageal cancer over the period 1984-2003 and found no evidence that incidence rates were 
higher in Norwich than the rest of England and Wales, although they did find a higher incidence 
of oesophageal cancer registrations in the County of Norfolk (Reacher et al. 2006).  There were, 
however, some limitations to this work, in particular rates and risks were not adjusted for age, sex 
or SES and, therefore, a second study was recommended and was carried out using the RIF.  
 
Incidence and mortality of oesophageal cancer (ICD9 150; ICD10 C15) for 1984-2003 (the same 
period as investigated by the HPA) were investigated at standard table (ST) ward level for 
Norfolk.  Wards or electoral divisions are key elements of UK administrative geography and refer 
to the spatial units used to elect local government councillors.  There are 7932 ST wards in 
England with an average population of 6200.  It was not possible to establish precisely which 
areas or populations were exposed to ZnCdS but at least one trial involved dispersion of ZnCdS 
over Norwich and, therefore, the population of Norwich could reasonably be identified as a 
potentially ‘exposed’ group. 
 
Indirectly standardised incidence (SIRs) and mortality (SMRs) ratios were calculated taking the 
population of England and Wales as a reference, and risks were adjusted for age, sex and SES.  
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Population data from each decennial census (1981, 1991, 2001) were used, with populations 
interpolated for intercensal years using data on population growth.  Adjustment for SES was by 
the Carstairs index (in quintiles), the 1991 census measure of deprivation (Carstairs and Morris 
1990), which combines data on male unemployment, car access, social class and overcrowding to 
allow geographical areas to be placed on a five point scale from least to most deprived.  
 
Risk of oesophageal cancer incidence (SIR) and mortality (SMR) 
Relative risks of oesophageal cancer incidence and mortality were not higher in Norwich than 
expected.  After adjustment for socio-economic status, risks were statistically significantly lower 
in women than would be expected (see Table 2).  Directly standardised incidence and mortality 
rates per 100,000 person years for Norwich were at the lower end of the range of those for 
England, reported to be 12.7-14.4 per 100,000 person-years in males and 8.6-9.3 per 100,000 in 
females for oesophageal cancer incidence (over the period 1991-1999), and 14.4 per 100,000 in 
males and 8.2 per 100,000 in females for oesophageal cancer mortality (1998) (Office for 
National Statistics 1999a & b). 
 
When risks of oesophageal cancer incidence were mapped by ward across Norfolk, no consistent 
patterns emerged (Figure 2).  The areas of highest risk for males and females differed, suggesting 
a common geographically determined exposure (such as ZnCdS) was unlikely to be influencing 
oesophageal cancer risk in the area.  The indirectly standardised risks across Norfolk are reported 
in Table 3.   
 
The RIF performs empirical Bayes smoothing of the raw relative risks to account for sampling 
variability in the observed data (Figure 2b).  Full Bayesian smoothing was also carried out by 
direct linkage to WinBUGs (Lunn 2000) (Figure 2c).  This approach allows computation of some 
measure of uncertainty, the posterior probability of an excess risk (Pr[RR>1|data], associated with 
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the smoothed risk values (Richardson et al. 2004).  These exceedence probabilities (Figure 2c) are 
also displayed in the RIF (Beale et al. 2008). 
 
The routinely collected data on cancer registrations and mortality did not provide evidence of an 
increased risk of oesophageal cancer incidence/mortality in the population of Norwich or Norfolk 
compared to England and Wales.  The disease mapping analysis did not reveal any areas with 
higher risks common to both males and females. 
 
Discussion 
Health and population data are increasingly becoming available; however, these data tend to be 
aggregated data to administrative geographies due to nature of data collection and/or 
confidentiality issues.  The use of aggregated data in epidemiology has associated problems 
nonetheless ecologic studies can be useful for detecting associations between exposure 
distributions and disease and can help target resources for further individual research.  Several 
statistical methods can be used to estimate area-level rates and risks that can be mapped to aid 
interpretation.  However, the availability of statistical techniques and tools to calculate and map 
small area risks does not necessarily ensure meaningful results are achieved.  All methods will be 
reliant on sufficient, accurate and complete underlying health and population data, as well as 
appropriate interpretation.  Biases, ecological or otherwise can be introduced into any spatial 
epidemiological study and the methods used in the RIF are no exception.  More details of 
limitations of spatial analysis are presented elsewhere (Beale et al. 2008), and are touched on 
below. 
 
When undertaking a risk analysis, the study area should be selected to represent a population 
exposed (or perceived to be) to the pollution source or pollutant of interest.  Accurately 
identifying the ‘at risk’ population is crucial and attempts should be made to reduce exposure 
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misclassification when, for example, using proxy variables or indirect exposure assessment 
(Hodgson et al. 2007).  A number of different methods for defining areas of exposure have been 
incorporated into the RIF including various methods to select specific areas geographically and 
spatially.  Distance from source can be used as a proxy for exposure although it can be difficult to 
define what distances reflect a meaningful exposure differential.  Ideally factors such as 
prevailing wind, topography, emissions etc. should be taken into account and a wide variety of 
GIS methods and bespoke dispersion models are now available to improve pollution modelling and 
exposure assessment and ata from these packages can be imported into the RIF to more accurately 
represent areas of exposure.  It should be noted, however, that no matter how well modelled, or 
how appropriately monitored, environmental levels do not necessarily equate to exposure (Briggs 
2003), and ecological data will not represent individual exposure. 
Ecological data do not offer the spatial accuracy that individual data afford and in addition to 
defining areas of exposure, effective selection of any affected populations is crucial.  In 
ecological analyses the total populations of an administrative region will be classed as exposed if 
that region falls within the defined exposure area.  However, using more complex spatial analysis, 
as permitted with GIS, users can reduce any 'over selection' of population by including areas 
based on the geometric centroid (in terms of its shape), or better still by using population-
weighted centroid data. Both geometric and population weighted centroids can be used to select 
potential at risk populations in the RIF, although only geometric centroids are dynamically 
calculated at runtime.  Of course, all GIS functions for spatial selection are available to users, or 
indeed they can specify the study population using prior knowledge. 
 
Aggregated data tend to be collected for administrative areas that can change over time, causing 
problems for long-term studies.  Further health and population data are often collected for 
administrative areas (e.g. census regions), whereas environmental data will often be collected or 
modelled, for different often non-conformable spatial areas.  Indeed, data are often needed for 
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geographical zones that do not correspond to administrative boundaries and effectively combining 
data with different spatial boundaries takes care and skill to minimize errors than can be 
introduced at this stage (Briggs et al 2008).  The scale of analysis will affect the results obtained.  
Indeed, results will be, in part, a consequence of the chosen resolution of the data because of the 
‘modifiable areal unit problem’ or MAUP (Openshaw 1984) and, therefore, observations are 
usually only relevant for the scale of analysis.  To avoid the ecological fallacy, associations 
observed in an ecological study should not be imputed to individuals. 
 
Attention must be given to the latency between exposure and disease onset to ensure the 
appropriate period of health data is utilised.  Populations can change over time, including between 
censuses, so as study years extend from a census year, population estimates can become 
increasing unreliable.  Interpolating between the census years can improve values but 
nevertheless this can be a source of error.  Indeed errors or variations in small-area population 
counts can create major uncertainties, especially where health events are rare.  In addition, for 
conditions with even a relatively short lag period, but especially for those endpoints, such as solid 
tumors, with lag periods of decades, the impact of population migration must be considered.  
Over time people will move in and out of the study area, or between exposure categories  In many 
cases lack of suitable data precludes effectively accounting for migration, however failure to take 
migration into account, particularly where migration rates are known to be high, can result in 
exposure misclassification, biased risk estimates and reduced study power, with the extent of 
migration bias related to both the magnitude and direction of the migration (Tong 2000).  There is 
a need to further develop and use suitable methods to deal with this bias in spatial 
epidemiological analysis and tools, such as the RIF. 
 
For some health end points, such as hospital admissions, the ascertainment of data can differ 
between areas with local variations introducing spurious spatial variation where higher disease 
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incidence might be due to specialist local centres, pro-active GPs, local disease registers or local 
screening programmes (Hansell et al. 2001).  Conversely, lower disease incidence might be due to 
rurality or boundary effects, with populations moving between administrative areas to seek 
treatment.  Furthermore, changes in the recording of health data e.g. changes between ICD 
revisions can introduce spurious temporal and/or spatial variation (Anderson et al. 2003). 
 
The RIF affords numerous time and efficiency savings compared to an ad hoc, study by study 
approach, however, the same care and consideration should be put into designing a RIF query as 
would be put into any other approach.  This includes appropriate consideration for exposure 
assessment, study population identification, choice of appropriate comparison population, 
mapping resolution, interpretation etc.   
 
 
Conclusion 
The RIF provides a valuable tool for initial analyses of environmental health problems, providing 
ecological risk estimates indicating the presence or absence of a public health problem.  The RIF 
cannot be used to assess individual-level associations or causal relationships, although evidence 
of an exposure-response relationship from a RIF study will provide support for undertaking a 
more costly individual-level study that may address causality.  Methods, such as those provided 
by the RIF, allow investigative studies to be carried out across large geographical areas and/or 
over long time periods avoiding constraining any analysis to a low number of cases, thereby 
increasing the statistical power to estimate the excess risk (Olsen et al. 1996).  Such studies may 
otherwise be too involved to provide timely responses to any public concerns. 
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The RIF is one of several tools that support EPHT work, and is designed to compliment already 
existing methods.  The RIF is distributed as freeware with documentation (Beale et al 2007), upon 
application, to the CDC EPHT program (http://www.cdc.gov/nceh/tracking) or SAHSU, Imperial 
College London (http://www.sahsu.org). 
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Tables 
Table 1: Indirectly standardised risks for leukemia, multiple mylemona, Hodgkin’s lymphoma and non-Hodgkin lymphoma around the five refinery 
facilities, Utah 
Health Endpoint (Yrs. 1973-2006)  
Distance 0-2.5km Adjusted for Age Adjusted for Age and Income Distance >2.5km Adjusted for Age Adjusted for Age and Income 
Gender Observed Expected SIR (%CI) Expected SIR (%CI) Observed Expected SIR (%CI) Expected SIR (%CI) 
Leukemia          
Male 103 101.88 1.01 (0.83-1.23) 103.52 1 (0.82-1.21) 145 140.46 1.03 (0.88-1.21) 140.82 1.03 (0.87-1.21) 
Female 80 79.63 1.00 (0.80-1.25) 79.88 1 (0.79-1.25) 100 106.96 0.93 (0.76-1.14) 108.08 0.93 (0.75-1.13) 
Male + Female 183 181.5 1.01 (0.87-1.17) 183.4 1 (0.86-1.15) 245 247.42 0.99 (0.87-1.12) 248.91 0.98 (0.87-1.12) 
Multiple Myeloma 
   
     
Male 34 36.84 0.92 (0.64-1.29) 36.99 0.92 (0.64-1.28) 52 50.69 1.03 (0.77-1.35) 50.07 1.04 (0.78-1.36) 
Female 34 30.73 1.11 (0.77-1.55) 30.93 1.1 (0.76-1.54) 35 41.70 0.84 (0.58-1.17) 40.48 0.86 (0.60-1.20) 
Male + Female 68 67.57 1.01 (0.78-1.28) 67.92 1 (0.78-1.27) 87 92.39 0.94 (0.75-1.16) 90.54 0.96 (0.77-1.19) 
Hodgkin’s lymphoma 
 
     
Male 26 25.42 1.02 (0.67-1.5) 26.70 0.97 (0.64-1.43) 34 37.49 0.91 (0.63-1.27) 37.68 0.90 (0.62-1.26) 
Female 27 21.29 1.27 (0.84-1.85) 21.45 1.26 (0.83-1.83) 30 29.55 1.02 (0.68-1.45) 31.85 0.94 (0.64-1.34) 
Male + Female 53 46.71 1.13 (0.85-1.48) 48.15 1.1 (0.82-1.44) 64 67.04 0.95 (0.74-1.22) 69.52 0.92 (0.71-1.18) 
non-Hodgkin lymphoma         
Male 148 118.23 1.25 (1.07-1.47) 119.45 1.24 (1.05-1.46) 184 165.75 1.11 (0.96-1.28) 165.75 1.11 (0.96-1.28) 
Female 118 108.30 1.09 (0.91-1.31) 107.88 1.09 (0.91-1.31) 141 147.21 0.96 (0.81-1.13) 146.90 0.96 (0.81-1.13) 
Male + Female 266 226.53 1.17 (1.04-1.32) 227.32 1.17 (1.04-1.32) 325 312.96 1.04 (0.93-1.16) 312.65 1.04 (0.93-1.16) 
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Table 2: Indirectly standardised risks and directly standardised rates of incidence and mortality from oesophageal cancer in Norwich (1984-2003), 
using the population of England and Wales as a reference. 
Oesophageal cancer (1984-2003) 
Indirectly standardised risks 
Incidence   Mortality  
 
 Adjusted for Age Adjusted for Age and SES   Adjusted for Age Adjusted for Age and SES 
Gender Observed Expected SIR (%CI) Expected SIR (%CI)  Observed Expected SIR (%CI) Expected SIR (%CI) 
Male 159 165.03 0.96 (0.82 – 1.13) 173.8 0.91 (0.78-1.07)  166 162.09 1.02 (0.88-1.19) 169.41 0.98 (0.84-1.14) 
Female 87 120.92 0.72 (0.58-0.89) 125.19 0.69 (0.56-0.86)  85 112.63 0.75 (0.6-0.93) 116.04 0.73 (0.59-0.91) 
Male + Female 246 285.95 0.86 (0.76-0.97) 298.99 0.82 (0.73-0.93)  166 162.09 1.02 (0.81-1.03) 285.46 0.88 (0.78-1) 
 
      
 Directly standardised rates 
Gender Observed Rate (per 100,000 pyrs) Rate (per 100,000 pyrs)  Observed Rate (per 100,000 pyrs) Rate (per 100,000 pyrs) 
Male 159 13.2 (11.3 - 15.44)  11.47 (9.38-14.03)  166 13.68 (11.74-15.94) 12.68 (10.12-15.9) 
Female 87 6.25 (5-7.72) 6.09 (4.52-7.94)  85 6.07 (4.84-7.52) 5.79 (4.28-7.57) 
Male + Female 246 9.64 (8.5-10.93) 8.71 (7.41-10.24)  251 9.78 (8.63-11.07) 9.15 (7.67-10.91) 
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Table 3: Indirectly standardised risks of oesophageal cancer in Norfolk (1984-2003), 
using the population of England and Wales as a reference 
 
 
Oesophageal cancer incidence (1984-2003): Indirectly standardised risks 
 
 Adjusted for Age Adjusted for Age and SES 
Gender Observed Expected SIR (%CI) Expected SIR (%CI) 
Male 1181 1239.33 0.95 (0.9-1.01) 1215.53 0.97 (0.92-1.03) 
Female 736 792.43 0.93 (0.86-1) 780.99 0.94 (0.88-1.01) 
Male + Female 1917 2031.76 0.94 (0.9-0.99) 1996.52 0.96 (0.92-1) 
 
